Epithelial discoidin domain-containing receptor
From Proteopedia
(Difference between revisions)
Line 4: | Line 4: | ||
== Function == | == Function == | ||
- | '''Epithelial discoidin domain-containing receptor | + | '''Epithelial discoidin domain-containing receptor''' (DDR1 and DDR2) are extracellular matrix-sensing receptors [[Tyrosine kinase]] which are activated by collagen and are expressed in bronchial epithelium. They are responsible for maintaining the normal structure of skin and kidney epithelia<ref>PMID:20884741</ref>. DDR1 and DDR2 function as sensors for extracellular matrix and to regulate a wide range of cell functions from migration and proliferation to cytokine secretion and extracellular matrix homeostasis/remodeling<ref name = "DDR1">PMID:24361528</ref>. |
== Disease == | == Disease == | ||
Line 21: | Line 21: | ||
</StructureSection> | </StructureSection> | ||
- | ==3D structures of epithelial discoidin domain-containing receptor 1== | + | ==3D structures of epithelial discoidin domain-containing receptor 1*Epithelial discoidin domain-containing receptor 1== |
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
+ | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
- | [[5bvk]] – hDDR1 kinase domain 564-913 – human<br /> | + | *Epithelial discoidin domain-containing receptor 1; Domains – discoidin 26-186; ligand-binding 283-385; kinase 543-838 |
- | [[3zos]], [[4bkj]] – hDDR1 kinase domain + cancer drug<br /> | + | |
- | [[6few]] – hDDR1 kinase domain + alport syndrome drug<br /> | + | **[[5bvk]] – hDDR1 kinase domain 564-913 – human<br /> |
- | [[6fex]], [[6fil]], [[6fim]], [[6fin]], [[6fio]], [[6fiq]] – hDDR1 kinase domain (mutant) + alport syndrome drug<br /> | + | **[[3zos]], [[4bkj]] – hDDR1 kinase domain + cancer drug<br /> |
- | [[4ckr]], [[5bvn]], [[5bvo]], [[5bvw]], [[5fdp]], [[5fdx]], [[6brj]], [[6gwr]] – hDDR1 kinase domain + inhibitor<br /> | + | **[[6few]] – hDDR1 kinase domain + alport syndrome drug<br /> |
- | [[4ag4]] – hDDR1 29-367 domain + antibody<br /> | + | **[[6fex]], [[6fil]], [[6fim]], [[6fin]], [[6fio]], [[6fiq]] – hDDR1 kinase domain (mutant) + alport syndrome drug<br /> |
+ | **[[4ckr]], [[5bvn]], [[5bvo]], [[5bvw]], [[5fdp]], [[5fdx]], [[6brj]], [[6gwr]] – hDDR1 kinase domain + inhibitor<br /> | ||
+ | **[[4ag4]] – hDDR1 29-367 domain + antibody<br /> | ||
+ | |||
+ | *Epithelial discoidin domain-containing receptor 2 | ||
+ | |||
+ | **[[2z4f]] – hDDR2 discoidin domain – NMR<br /> | ||
+ | **[[2wuh]] – hDDR2 discoidin domain + collagen<br /> | ||
+ | **[[6fer]] – hDDR2 kinase domain + inhibitor<br /> | ||
+ | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Revision as of 09:00, 31 December 2018
|
3D structures of epithelial discoidin domain-containing receptor 1*Epithelial discoidin domain-containing receptor 1
Updated on 31-December-2018
References
- ↑ Roberts ME, Magowan L, Hall IP, Johnson SR. Discoidin domain receptor 1 regulates bronchial epithelial repair and matrix metalloproteinase production. Eur Respir J. 2011 Jun;37(6):1482-93. doi: 10.1183/09031936.00039710. Epub 2010, Sep 30. PMID:20884741 doi:http://dx.doi.org/10.1183/09031936.00039710
- ↑ 2.0 2.1 Borza CM, Pozzi A. Discoidin domain receptors in disease. Matrix Biol. 2014 Feb;34:185-92. doi: 10.1016/j.matbio.2013.12.002. Epub 2013 Dec, 19. PMID:24361528 doi:http://dx.doi.org/10.1016/j.matbio.2013.12.002
- ↑ Song J, Chen X, Bai J, Liu Q, Li H, Xie J, Jing H, Zheng J. Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells. Tumour Biol. 2016 Aug;37(8):11509-21. doi: 10.1007/s13277-016-5021-2. Epub 2016, Mar 28. PMID:27020590 doi:http://dx.doi.org/10.1007/s13277-016-5021-2
- ↑ Toy KA, Valiathan RR, Nunez F, Kidwell KM, Gonzalez ME, Fridman R, Kleer CG. Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer. Breast Cancer Res Treat. 2015 Feb;150(1):9-18. doi: 10.1007/s10549-015-3285-7., Epub 2015 Feb 10. PMID:25667101 doi:http://dx.doi.org/10.1007/s10549-015-3285-7
- ↑ Canning P, Tan L, Chu K, Lee SW, Gray NS, Bullock AN. Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors. J Mol Biol. 2014 Apr 22. pii: S0022-2836(14)00198-3. doi:, 10.1016/j.jmb.2014.04.014. PMID:24768818 doi:http://dx.doi.org/10.1016/j.jmb.2014.04.014
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Joel L. Sussman, Jaime Prilusky